Intensity-Modulated Radiotherapy as Primary Therapy for Prostate Cancer: Report on Acute Toxicity After Dose Escalation With Simultaneous Integrated Boost to Intraprostatic Lesion
- 1 November 2008
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 72 (3), 799-807
- https://doi.org/10.1016/j.ijrobp.2008.01.040
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialThe Lancet Oncology, 2007
- Radiation dose and late failures in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the ProstateJAMA, 2005
- Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Prostate Cancer Radiotherapy Dose Response: An Update of the Fox Chase ExperienceJournal of Urology, 2004
- The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancerCancer, 2004
- Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2002
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Radical Radiation for Localized Prostate Cancer: Local Persistence of Disease Results in a Late Wave of MetastasesJournal of Clinical Oncology, 2002